Natus Medical Inc (BABY) Analysts See $0.33 EPS

June 19, 2017 - By Maria Brooks

 Natus Medical Inc (BABY) Analysts See $0.33 EPS
Investors sentiment increased to 1.93 in Q4 2016. Its up 0.82, from 1.11 in 2016Q3. It improved, as 11 investors sold Natus Medical Inc shares while 56 reduced holdings. 51 funds opened positions while 78 raised stakes. 29.10 million shares or 6.34% more from 27.36 million shares in 2016Q3 were reported.
Howe And Rusling invested in 0% or 160 shares. Gotham Asset Mngmt Limited Liability accumulated 147,129 shares. Tdam Usa reported 0.05% stake. Rainier Management Llc has invested 0.54% in Natus Medical Inc (NASDAQ:BABY). Piermont Capital Mngmt Incorporated invested 0.1% of its portfolio in Natus Medical Inc (NASDAQ:BABY). Princeton Alpha Mngmt L P invested 0.1% of its portfolio in Natus Medical Inc (NASDAQ:BABY). Goldman Sachs Group holds 0% or 132,632 shares. Renaissance Limited Co invested in 45,800 shares or 0% of the stock. Henderson Gp Plc holds 497,194 shares or 0.13% of its portfolio. Old Mutual Global (Uk) owns 14,889 shares. Moreover, Geneva Advsr Ltd Liability Corporation has 0.02% invested in Natus Medical Inc (NASDAQ:BABY). Rice Hall James & Assocs invested in 474,316 shares. Fiera Capital Corp reported 308,963 shares. Quantbot Technologies L P stated it has 7,186 shares or 0.03% of all its holdings. 63,706 were reported by Pnc Fin Gp.

Since February 9, 2017, it had 2 insider purchases, and 3 sales for $190,940 activity. 5,000 shares were sold by GUNST ROBERT A, worth $180,000 on Thursday, February 9. HAWKINS JAMES B had bought 6,000 shares worth $202,860 on Wednesday, May 31. MOORE WILLIAM M also sold $186,300 worth of Natus Medical Inc (NASDAQ:BABY) shares.

Analysts await Natus Medical Inc (NASDAQ:BABY) to report earnings on July, 19. They expect $0.33 EPS, down 15.38 % or $0.06 from last year’s $0.39 per share. BABY’s profit will be $11.07M for 26.64 P/E if the $0.33 EPS becomes a reality. After $0.30 actual EPS reported by Natus Medical Inc for the previous quarter, Wall Street now forecasts 10.00 % EPS growth. About 51,161 shares traded. Natus Medical Inc (NASDAQ:BABY) has risen 4.38% since June 19, 2016 and is uptrending. It has underperformed by 12.32% the S&P500.

Natus Medical Inc (NASDAQ:BABY) Ratings Coverage

Among 4 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Natus Medical had 7 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was upgraded by Raymond James to “Outperform” on Tuesday, September 13. Roth Capital maintained the stock with “Buy” rating in Tuesday, April 5 report. TH Capital maintained Natus Medical Inc (NASDAQ:BABY) rating on Tuesday, January 12. TH Capital has “Buy” rating and $50.0 target. On Tuesday, October 4 the stock rating was initiated by Benchmark with “Buy”. The rating was maintained by TH Capital on Thursday, July 23 with “Buy”. The stock of Natus Medical Inc (NASDAQ:BABY) has “Buy” rating given on Thursday, October 22 by TH Capital. Raymond James downgraded the shares of BABY in report on Thursday, February 2 to “Mkt Perform” rating.

Natus Medical Incorporated is a provider of newborn care and neurology healthcare services and products used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company has market cap of $1.18 billion. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It has a 32.38 P/E ratio.

More notable recent Natus Medical Inc (NASDAQ:BABY) news were published by: Fool.com which released: “Natus Medical Inc. Fell 11% in April. Here’s Why.” on May 08, 2017, also Fool.com with their article: “Natus Medical Incorporated in 4 Charts” published on December 05, 2016, Fool.com published: “Why Natus Medical Inc. Sank Today” on April 26, 2017. More interesting news about Natus Medical Inc (NASDAQ:BABY) were released by: Fool.com and their article: “Why Natus Medical Inc Slipped Today” published on September 26, 2016 as well as Fool.com‘s news article titled: “Natus Medical Inc Hears a Bright 2017” with publication date: February 02, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.